<< مقالات لاتين >>
<< بر اساس عنوان >>
1
PFGE characterisation and adhesion ability of Listeria monocytogenes isolates obtained from bovine carcasses and beef processing facilities
2
PFGE genotyping and antimicrobial susceptibility of Campylobacter in retail poultry meat in Estonia
3
PFGE genotyping and molecular characterization of Campylobacter spp. isolated from chicken meat
4
PFG-NMR approach to determining the water transport mechanism in polymer electrolyte membranes conditioned at different temperatures
5
PFG-NMR self-diffusion in casein dispersions: Effects of probe size and protein aggregate size
6
PFHC: A clustering algorithm based on data partitioning for unevenly distributed datasets
7
Pfiesteria piscicida and Pfiesteria shumwayae in coastal waters of Long Island, New York, USA
8
Pfiesteria: Harmful Algal Blooms as Indicators of Human: Ecosystem Interactions
9
P-filters and hereditary Baire function spaces
10
P-Filters and the perfect set property
11
p-Filtrations and the Steinberg Module
12
Pfisterʹssubform theorem for reduced special groups
13
Pfizer CEOʹs call to action
14
Pfizer Diflucan Partnership Program
15
Pfizer loses sildenafil case in Australia
16
PFKFB3 Promotes Liver Fibrosis by Regulating Aerobic Glycolysis of Hepatic Stellate Cells
17
PFKFB3 Regulates Oxidative Stress Homeostasis via Its S-Glutathionylation in Cancer
18
PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer
19
Pflanzenphysiologie, P. Schopfer, A. Brennicke. Springer Verlag, Berlin, Heidelberg (1999)
20
PF-MPC: Particle filter-model predictive control
21
PfMyb1, a Plasmodium falciparum Transcription Factor, is Required for Intra-erythrocytic Growth and Controls Key Genes for Cell Cycle Regulation Original Research Article
22
PFOS and PFOA in the livers of harbour porpoises (Phocoena phocoena) stranded or bycaught around the UK
23
p-Fractals and power series–I. Some 2 variable results
24
p-Fractals and power series—II.: Some applications to Hilbert–Kunz theory
25
PFS for Mars Express: A new approach to study Martian atmosphere Original Research Article
26
PFS on Mars Express: preparing the analysis of infrared spectra to be measured by the Planetary Fourier Spectrometer
27
PFS/MEX observations of the condensing CO2 south polar cap of Mars
28
PFS: an effective instrument for the study of martian environment Original Research Article
29
PFS-MEX observation of ices in the residual south polar cap of Mars
30
P-functions, Quasi-convex Functions, and Hadamard-type Inequalities1
31
PG 1613+426: A new sdB pulsator
32
PG&E files U.S. suit to halt destec-modesto-praxair deal
33
PG&E proposes its own retail customer accesss
34
PG&E, SCE sell 10,000 MW in plants above book value
35
pg4DB: A fuzzy object-relational system
36
PGA1 and PGA2 are selective ligands for the EP2 and EP4 prostaglandin receptor subtypes
37
PGAIPG, a Repeated Hexapeptide of Bovine and Human Tropoelastin, Is Chemotactic for Neutrophils and Lewis Lung Carcinoma Cells
38
PGAIPG, a Repeated Hexapeptide of Bovine and Human Tropoelastin, Is Chemotactic for Neutrophils and Lewis Lung Carcinoma Cells
39
PGAMgnam Style: A Glycolytic Switch Controls Biosynthesis
40
PGC-1α is induced by parathyroid hormone and coactivates Nurr1-mediated promoter activity in osteoblasts
41
PGC1-α mRNA expression cross talk with tumor volume growth and total antioxidant capacity in breast cancer model mice: following discontinuous aerobic exercise and vitamin D intake
42
PGD for aneuploidy screening: an expensive hoax?
43
PGE and Os isotopic analyses of single sample aliquots with NiS fire assay preconcentration
44
PGE and Os-isotopic variations in lavas from Kohala Volcano, Hawaii: Constraints on PGE behavior and melt/crust interaction
45
PGE enrichment in chromitite layers and the Merensky Reef of the western Bushveld Complex; a Re¯Os and Rb¯Sr isotope study
46
PGE enrichment in chromitite layers and the Merensky Reef of the western Bushveld Complex; a Re–Os and Rb–Sr isotope study
47
PGE geochemistry and Re–Os dating of massive sulfide ores from the Baimazhai Cu–Ni deposit, Yunnan province, China
48
PGE geochemistry of the Fengshan porphyry–skarn Cu–Mo deposit, Hubei Province, Eastern China
49
PGE mineralization in marginal sulfide ores of the Chineisky layered intrusion, Russia
50
PGE mineralization in the late Archaean iron-rich mafic-ultramafic Hanumalapur Complex, Karnataka, India
51
PGE reefs as an in situ crystallization phenomenon: the Nadezhda gabbronorite body, Lukkulaisvaara layered intrusion, Fennoscandian Shield, Russia
52
PGE Wins Contract to Serve New Palm Springs Muni
53
PGE2 induces oenocytoid cell lysis via a G protein-coupled receptor in the beet armyworm, Spodoptera exigua
54
PGE2 production is suppressed by chemically-synthesized Δ7-eicosatrienoic acid in macrophages through the competitive inhibition of COX-2
55
PGE2 targets squamous cell carcinoma cell with the activated epidermal growth factor receptor family for survival against 5-fluorouracil through NR4A2 induction
56
PGEN: an integrated model of leaf photosynthesis, transpiration, and conductance
57
PGEN: an integrated model of leaf photosynthesis, transpiration, and conductance
58
PGEs and other traffic-related elements in roadside soils from Sa˜o Paulo, Brazil
59
PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity
60
P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil
61
P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER).
62
P-glycoprotein activity in renal clear cell carcinoma
63
P-glycoprotein and sister P-glycoprotein sequences from mummichog, Fundulus heteroclitus, liver and intestine
64
P-Glycoprotein expression by human colonic tumor cells influences the growth of tumor cells in vitro
65
P-glycoprotein expression in human major and minor salivary glands
66
P-glycoprotein expression in Perna viridis after exposure to Prorocentrum lima, a dinoflagellate producing DSP toxins
67
P-glycoprotein in autoimmune diseases
68
P-GLYCOPROTEIN IN BLOOD BRAIN BARRIER
69
P-glycoprotein induction: an antidotal pathway for paraquat-induced lung toxicity
70
P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus
71
P-glycoprotein is downregulated in KG1a-primitive leukemia cells by LDL cholesterol deprivation and by HMG-CoA reductase inhibitors
72
P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway
73
P-GLYCOPROTEIN QUANTITATION IN ACUTE LEUKEMIA
74
P-glycoprotein: Its role in drug resistance
75
P-Glycoprotein-Mediated Efflux and Drug Sequestration in Lysosomes Confer Advantages of K562 Multidrug Resistance Sublines to Survive Prolonged Exposure to Cytotoxic Agents
76
P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice
77
P-glycoproteins are not released into bile
78
PGM beamline with constant energy resolution mode for U49-2 undulator at BESSY-II
79
PGM beamline with constant energy resolution mode for U49-2 undulator at BESSY-II
80
PGO: A parallel computing platform for global optimization based on genetic algorithm
81
Pgp deficiency increases amyloid concetrations in the brain
82
PGP4, an ATP Binding Cassette P-Glycoprotein, Catalyzes Auxin Transport in Arabidopsis thaliana Roots
83
PGPR-induced defense responses in the tea plant against blister blight disease
84
pGPro1, a novel binary vector for monocot promoter characterization
85
PGR5 Is Involved in Cyclic Electron Flow around Photosystem I and Is Essential for Photoprotection in Arabidopsis
86
P-graph methodology for cost-effective reduction of carbon emissions involving fuel cell combined cycles
87
p-groups in the Betti-Mathieu group Original Research Article
88
p-GROUPS OF AUTOMORPHISMS OF ABELIAN p-GROUPS
89
p-Groups of Small Breadth
90
p-GROUPS WITH A SMALL NUMBER OF CHARACTER DEGREES AND THEIR NORMAL SUBGROUPS
91
PGRP-SC2 Promotes Gut Immune Homeostasis to Limit Commensal Dysbiosis and Extend Lifespan
92
PGS and the Critical Decision on Transfer of Defective Embryos
93
PGSE diffusion NMR studies on mononuclear and dinuclear cationic platinum salts of (S)-MeO-Biphep and (R)-p-tolyl-BINAP
94
PGSS-drying: Mechanisms and modeling
95
p-Guanidinoethyl calixarene and parent phenol derivatives exhibiting antibacterial activities. Synthesis and biological evaluation Original Research Article
96
pH – Specific synthesis, spectroscopic, and structural characterization of an assembly of species between Co(II) and N,N-bis(phosphonomethyl)glycine. Gaining insight into metal-ion phosphonate interactions in aqueous Co(II)–organophosphonate systems
97
pH adjustment for seasonal control of UF fouling by natural waters Original Research Article
98
pH Affects the Thermal Inactivation Parameters of R-Phycoerythrin from Porphyra yezoensis
99
pH and biogeochemical processes in the Gotland Basin of the Baltic Sea
100
pH and buffering capacity problems involved in the determination of ammonia in saline water using the indophenol blue spectrophotometric method
101
pH and buffering capacity problems involved in the determination of ammonia in saline water using the indophenol blue spectrophotometric method Original Research Article
102
pH and electro-responsive release behavior of MWCNT/PVA/PAAc composite microcapsules
103
pH- and glucose-sensitive glycopolymer nanoparticles based on phenylboronic acid for triggered release of insulin
104
pH and glutathion-responsive hydrogel for localized delivery of paclitaxel
105
pH and grain-size variation in leaching tests with bricks made of harbour sediments compared to commercial bricks
106
pH and heat-induced structural changes of bovine apo-α-lactalbumin
107
pH and hydrogen peroxide dual responsive supramolecular prodrug system for controlled release of bioactive molecules
108
pH and ionic strength effect on single fibrinogen molecule adsorption on mica studied with AFM
109
pH- and metal-dependent structural diversity from mononuclear to two-dimensional polymers based on a flexible tricarboxylate ligand
110
pH- and mol-ratio dependent formation of zinc(II) coordination polymers with iminodiacetic acid: Synthesis, spectroscopic, crystal structure and thermal studies
111
pH- and mol-ratio dependent tungsten(VI)–citrate speciation from aqueous solutions: syntheses, spectroscopic properties and crystal structures
112
pH and pCO2 microelectrode measurements and the diffusive behavior of carbon dioxide species in coastal marine sediments
113
pH and redox-responsive mixed micelles for enhanced intracellular drug release
114
pH and salt effects on chiral separations using affinity ultrafiltration Original Research Article
115
pH and salt responsive poly(N,N-dimethylaminoethyl methacrylate) cylindrical brushes and their quaternized derivatives
116
pH and salt-induced reversible aggregation of nonionic synthetic glycolipid vesicles
117
pH and solute concentration of suspension media affect the outcome of high hydrostatic pressure treatment of Listeria monocytogenes
118
pH- and sugar-sensitive layer-by-layer films and microcapsules for drug delivery
119
pH and surface tension dependence of mixed sodium deoxycholate–sodium dehydrocholate pre-micellar aggregation in aqueous solution
120
pH and temperature dependence of particle size in Pb1−xFexS nanoparticle films
121
pH and temperature dependent facile precipitation of nano-goethite particles in Fe(NO3)3–NaOH–NH3NH2HSO4–H2O medium
122
pH and temperature responsive porous membranes via an in situ bulk copolymerization approach
123
pH- and temperature-dependent release from cationic vesicles coexisting with copolymer of N-isopropylacrylamide and methacrylic acid
124
pH- and temperature-responsive amphiphilic diblock copolymers of 4-vinylpyridine and oligoethyleneglycol methacrylate synthesized by RAFT polymerization
125
pH- and temperature-responsive hydrogels from crosslinked triblock copolymers prepared via consecutive atom transfer radical polymerizations
126
pH- and temperature-responsive poly(aspartic acid)-l-poly(N-isopropylacrylamide) conetwork hydrogel
127
pH- and temperature-sensitive multiblock copolymer hydrogels composed of poly(ethylene glycol) and poly(amino urethane)
128
pH- and temperature-sensitive permeation through polyelectrolyte complex films composed of chitosan and polyalkyleneoxide–maleic acid copolymer
129
pH- and thermo-multi-responsive fluorescent micelles from block copolymers via reversible addition fragmentation chain transfer (RAFT) polymerization
130
pH- and thermo-responsive microcontainers as potential drug delivery systems: Morphological characteristic, release and cytotoxicity studies
131
pH- and thermosensitive thin lipid layer coated mesoporous magnetic nanoassemblies as a dual drug delivery system towards thermochemotherapy of cancer
132
pH- and time-dependent hemoglobin transitions: A case study for process modelling Original Research Article
133
p–H and T–S diagrams of 3He from 0.2 K to 20 K Original Research Article
134
pH changes in peralkaline late-magmatic fluids
135
pH changes of self-etching primers mixed with powdered dentine
136
pH control for enhanced reductive bioremediation of chlorinated solvent source zones Original Research Article
137
pH control of the structure, composition, and catalytic activity of sulfated zirconia
138
pH control on oxygen isotopic composition of symbiotic corals
139
pH control strategy in astaxanthin fermentation bioprocess by Xanthophyllomyces dendrorhous
140
pH control strategy of batch microbial transglutaminase production with Streptoverticillium mobaraense
141
pH control: handling nonlinearity and deadtime with fuzzy relational model-based control
142
pH controlled condensation of polysiloxane networks at the water–air interface
143
pH Controlled Dispersion of Non-oxide Ceramic Powders in Aqueous Media
144
pH Controlled Dispersion of Non-oxide Ceramic Powders in Aqueous Media
145
pH controlled emission of ruthenium(II)–tris–bipyridine complexes
146
pH controlled selective transport of proteins through charged ultrafilter membranes under coupled driving forces: An efficient process for protein separation
147
pH controlled size/shape in CTAB micelles with solubilized polar additives: A viscometry, scattering and spectral evaluation
148
pH controlled supramolecular structures of new silver(I) complexes based on 2-sulfoterephthalic acid and 4,4′-bipyridine
149
pH controls over anaerobic carbon mineralization, the efficiency of methane production, and methanogenic pathways in peatlands across an ombrotrophic–minerotrophic gradient
150
pH controls over anaerobic carbon mineralization, the efficiency of methane production, and methanogenic pathways in peatlands across an ombrotrophic–minerotrophic gradient
151
pH dependant sticking probability of gold colloid on silicon
152
pH dependence and thermodynamics of Hg(II) adsorption onto chitosan-poly(vinyl alcohol) hydrogel adsorbent
153
pH dependence of electrokinetic behavior of dolomite and magnesite in aqueous electrolyte solutions
154
pH Dependence of ferrous sorption onto two smectite clays
155
pH dependence of heme electrochemistry in cytochromes investigated by multiconformation continuum electrostatic calculations
156
pH Dependence of inhibitors targeting the occluding loop of cathepsin B
157
pH dependence of PDMS–PMAA IPN morphology and transport properties
158
pH Dependence of reactive sites of curcumin possessing antioxidant activity and free radical scavenging ability studied using the electrochemical and ESR techniques: Polyaniline used as a source of the free radical
159
pH dependence of steroid hormone—organic matter interactions at environmental concentrations Original Research Article
160
pH dependence of tailing in reversed-phase chromatography of a cationic dye: measurement of the strong adsorption site surface density
161
pH dependence of the absorption and emission behaviour of lumiflavin in aqueous solution
162
pH dependence of the composition and stability of MnIII–bicarbonate complexes and its implication for redox interaction of MnII with photosystem II
163
pH dependence of the dissociation of multimeric hemoglobin probed by high hydrostatic pressure Original Research Article
164
pH dependence of the fluorescence lifetime of enhanced yellow fluorescent protein in solution and cells
165
pH Dependence of the Folding of Intestinal Fatty Acid Binding Protein
166
pH dependence of the hydrophobicity of β-blocker amine compounds measured by counter-current chromatography
167
pH Dependence of the rate of DNA alkylation for (+)-duocarmycin SA and (+)-CCBI-TMI
168
pH Dependence of the Reaction Rate ofp-Bromophenacyl Bromide and of the Binding Constants of Ca2+and an Amide-Type Substrate Analog to Bovine Pancreatic Phospholipase A2
169
pH dependence of the reactions of arsenazo III with the lanthanides
170
pH dependency of ligand binding to cellobiohydrolase 1 (Cel7A): Affinity, selectivity and inhibition for designed propranolol analogues
171
pH dependency of serum ionised calcium Original Research Article
172
pH dependent binding of chlorin-p6 with phosphatidyl choline liposomes
173
pH Dependent binding of chlorin-p6 with phosphatidyl choline liposomes: Comparison between one and two-photon excited fluorescence
174
pH dependent conformational and structural changes of xylanase from an alkalophilic thermophilic Bacillus sp (NCIM 59)
175
pH dependent copper binding properties of a CuA azurin variant with both bridging cysteines replaced with serines
176
pH dependent dynamic behavior of flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) in femtosecond to nanosecond time scale
177
pH dependent fluorescence switching in salicylideneaniline: ‘off–on–off’ operation controlled by surfactant micelles
178
pH Dependent formations of dinuclear molybdenum(V) and incomplete cubane molybdenum(IV) complexes with nitrilotriacetate
179
pH dependent growth of poly(L-lysine)/poly(L-glutamic) acid multilayer films and their cell adhesion properties
180
pH dependent interaction of biofunctionalized CdS nanoparticles with nucleobases and nucleotides: A fluorimetric study
181
pH dependent phosphate hydrolysis by a lanthanide EF-hand peptide
182
pH Dependent photophysics and role of medium on photoinduced electron transfer between ruthenium polypyridyl complex and anthraquinone
183
pH dependent protein stability: A quantitative approach based on Kramerʹs barrier escape
184
pH dependent reversible aggregation of Chitosan and glycol-Chitosan stabilized silver nanoparticles
185
pH dependent self assembly of (beta)-amyloid(10-35) and (beta)amyloid(10-35)-PEG3000
186
pH Dependent self-assembly of dimetallic lanthanide complexes
187
pH Dependent structural diversity of lead compounds based on new flexible ligand [3-(2-pyridyl)-1-pyrazolyl] acetic acid
188
pH dependent surface enhanced Raman study of Phe + Ag complex and DFT calculations for spectral analysis
189
pH dependent uptake of porphyrin-type photosensitizers by solid tumor cells in vitro is not induced by modification of transmembrane potential
190
PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt
191
PH effect in the photocatalytic transformation of a phenyi-urea herbicide
192
pH effect on cysteine and cystine behaviour at hanging mercury drop electrode
193
pH effect on OH radical production in photo/ferrioxalate system
194
pH Effect on the binding of chlorin derivatives with Cremophor EL, a potential drug delivery vehicle
195
pH effect on the electrochemical redox reaction of disulfide with polyaniline film electrode in organic solution
196
pH Effect on the Size of Graphene Quantum dot Synthesized by Using Pulse Laser Irradiation
197
pH Effect on the spectroscopic behavior and photoinduced generation of semiquinone anion radical of hypocrellin B
198
pH effects on collagen fibrillogenesis in vitro: Electrostatic interactions and phosphate binding
199
pH effects on drug interactions with lipid bilayers by liposome electrokinetic chromatography
200
pH effects on optical and DNA binding properties of a thiophene-containing ruthenium(II) complex
201
pH effects on the adherence and fouling propensity of extracellular polymeric substances in a membrane bioreactor
202
pH effects on the binding of oxygen to non-vertebrate monomeric hemoglobins. A linked function model.
203
pH effects on the cellular uptake of four photosensitizing drugs evaluated for use in photodynamic therapy of cancer
204
pH effects on the hyaluronan hydrolysis catalysed by hyaluronidase in the presence of proteins. Part III. The electrostatic non-specific hyaluronan–hyaluronidase complex
205
pH effects on the hyaluronan hydrolysis catalysed by hyaluronidase in the presence of proteins: Part II. The electrostatic hyaluronan – Protein complexes
206
pH effects on the second-order nonlinear optical properties of surface modified CdS nanoparticles
207
pH evolution in sea ice grown at an outdoor experimental facility
208
P–H functionalised phosphinoalkoxides as ligands: synthesis and catalytic properties of [Cp2Zr(Me)(cyclo-1-O-2-PH(Tipp)-C6H10)] (Tipp=2,4,6-Pri3C6H2), [Cp2Zr(Me)(cyclo-1-O-2-PH(Tipp){Mo(CO)5}–C6H10)] and [Cp2Zr(BH4)(cyclo-1-O-2-PH(Mes)(BH3)–C6H10)] (Mes=2
209
pH gradient high-performance liquid chromatography: theory and applications
210
pH gradient reversed-phase liquid chromatography as a fractionation tool for the separation of peptides
211
pH has a role in cystic fibrosis infections
212
pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque
213
pH HOMEOSTASIS OF THE CIRCADIAN SPORULATION RHYTHM IN CLOCK MUTANTS OF NEUROSPORA CRASSA
214
pH Independent Complexation of 2-Aminobenzimidazole with β-cyclodextrin
215
pH indications in aqueous organic photodecompositions with carbonyl and hydroxyl groups
216
pH Induced Aggregation and Weak Gel Formation of Whey Protein Polymers
217
pH influence on root growth and nutrient uptake of Pinus pinaster seedlings
218
pH influence on sorption characteristics of heavy metal in the vadose zone
219
pH Influence on the stability of foams with protein–polysaccharide complexes at their interfaces
220
pH is a good predictor of the distribution of anoxygenic purple phototrophic bacteria in Arctic soils
221
pH is a good predictor of the distribution of anoxygenic purple phototrophic bacteria in Arctic soils
222
pH measurement and control in solvent extraction using column contractors
223
pH MEASUREMENT USING MICRO GAP STRUCTURE
224
pH Metric, Spectroscopic and Thermodynamic Study of Complexation Behavior of 2-aminobenzothiazole with Ni (II) in Presence of Amino Acids
225
pH microelectrode–micropipette system for the measurement of enzyme reactions in a picoliter volume of a living plant cell Original Research Article
226
pH modelling by neural networks. Application of control and validation data series in the Middle Loire river
227
pH modelling by neural networks. Application of control and validation data series in the Middle Loire river
228
pH Modulates the Quinone Position in the Photosynthetic Reaction Center from Rhodobacter sphaeroides in the Neutral and Charge Separated States
229
pH modulation of transport properties of alamethicin oligomers inserted in zwitterionic-based artificial lipid membranes Original Research Article
230
pH neutralization and influence on mechanical strength in self-adhesive resin luting agents
231
pH of activated carbon surface as an indication of its suitability for H2S removal from moist air streams Original Research Article
232
pH of seawater
233
pH of soul: How does acid-base balance affect our cognition?
234
pH of the Martian surface
235
pH optical sensors based on sol–gels: Chemical doping versus covalent immobilization Original Research Article
236
pH Oscillations and complex reaction dynamics in the non-buffered chlorite–thiourea reaction
237
pH polymeric membrane microelectrodes based on neutral carriers and their application in aquatic environments Original Research Article
238
pH pre-corrected liquid hot water pretreatment on corn stover with high hemicellulose recovery and low inhibitors formation
239
pH programming in capillary electrophoresis by means of temperature programming
240
pH regulates key players of nitrification in paddy soils
241
pH regulates key players of nitrification in paddy soils
242
pH regulation as a method of intensification of soil electroremediation
243
pH regulation during ischaemia-reperfusion of isolated rat hearts, and metabolic effects of 2,3-butanedione monoxime
244
pH Regulation in Anoxic Plants
245
pH regulation of alkaline wastewater with carbon dioxide: A case study of treatment of brewery wastewater in UASB reactor coupled with absorber
246
pH regulation of carbon and nitrogen dynamics in two agricultural soils
247
pH regulation of carbon and nitrogen dynamics in two agricultural soils
248
pH responsive “off–on–off” luminescent switch of a novel ruthenium(II) complex [Ru(bpy)2(pipipH2)]2+
249
pH responsive cross-linked polymeric matrices based on natural polymers: effect of process variables on swelling characterization and drug delivery properties
250
pH responsive itaconic acid grafted alginate microspheres for the controlled release of nifedipine
251
pH responsive luminescent switches of ruthenium(II) complexes containing two imidazole groups: Synthesis, spectroscopy, electrochemistry and theoretical calculations
252
pH Responsive micelle self-assembled from a new amphiphilic peptide as anti-tumor drug carrier
253
pH responsiveness of two-layer nano-composite membrane with ultrathin cylindrical nanopores PS-b-P4VP film
254
pH sensing in living cells using fluorescent microspheres
255
pH sensitive halloysite-sodium hyaluronate/poly(hydroxyethyl methacrylate) nanocomposites for colon cancer drug delivery
256
pH Sensitive Hydrogel Based Acrylic Acid for Controlled Drug Release
257
pH Sensitive Hydrogel Based on Poly(Acrylic Acid) and Cellulose Nanocrystals
258
pH sensitive N-succinyl chitosan grafted polyacrylamide hydrogel for oral insulin delivery
259
pH sensitive photoconductor based on poly(para-phenylene-vinylene)
260
pH sensitive photoconductor based on poly(para-phenylene-vinylene)
261
pH Sensitive polypropylene porous membrane prepared by grafting acrylic acid in supercritical carbon dioxide
262
pH sensitive silica nanotubes as rationally designed vehicles for NSAIDs delivery
263
pH Sensitive supramolecular assembling system between a new linear water soluble β-cyclodextrin terpolymer and an amphiphilic poly(ethylene oxide)
264
pH sensitivity of polyaniline and its substituted derivatives
265
pH sensor based on a detection sol–gel layer onto optical fiber
266
pH sensor based on deposited film of lead oxide on aluminum substrate electrode
267
pH sensor based on the crown heteropolyanion K28Li5H7P8W48O184·92H2O immobilized using a layer by layer assembly process
268
pH sensors with lithium lanthanum titanate sensitive material: applications in food industry
269
pH sequential ozonation of domestic and wine-distillery wastewaters
270
pH simulation model in a mixed layer of a lacustrine environment (the case of Lake Orta)
271
pH simulation model in a mixed layer of a lacustrine environment (the case of Lake Orta)
272
pH stress can cause cell elongation in Bacillus and Clostridium species: a research note
273
pH Switched sensitisation of europium(III) by a dansyl group
274
pH switching on-off semi-IPN hydrogel based on cross-linked poly(acrylamide-co-acrylic acid) and linear polyallyamine
275
pH transients in hydroxyapatite chromatography columns—Effects of operating conditions and media properties
276
pH Transients in hydroxyapatite chromatography columns—Experimental evidence and phenomenological modeling
277
pH transitions in cation exchange chromatographic columns containing weak acid groups
278
pH Transitions in Ion-Exchange Systems: Role in the Development of a Cation-Exchange Process for a Recombinant Protein
279
pH triggered release of protective poly(ethylene glycol)-b-polycation copolymers from liposomes
280
pH tunable morphology of the gold nanoparticles produced by citrate reduction
281
pH value and ionic strength effects on the adsorption kinetics of protein/phospholipid at the chloroform/water interface
282
pH Value controlled structures: from macrocyclic complex monomer to 2D macrocyclic sheet
283
pH value dependence of the photothermal and optical absorption spectra for polyaniline films
284
pH variability and CO2 induced acidification in the North Sea
285
pH, alkalinity and total CO2 in coastal seawater by potentiometric titration with a difference derivative readout Original Research Article
286
pH, Dissolved Oxygen, and Adsorption Effects on Metal Removal in Anaerobic Bioreactors
287
pH, Photo, and Aeration Period Effects on Arthrospira maxima Growth: Taguchi Technique
288
pH, serum proteins and ionic strength influence the uptake of merocyanine 540 by WiDr cells and its interaction with membrane structures
289
Ph.D. in Business Management at Istanbul University: A New Programme in English Ready to Commence in Fall 2016
290
Ph.D. in Nursing from Theory to Reality
291
Ph.D. Students of Irving Segal
292
pH/redox responsive core cross-linked nanoparticles from thiolated carboxymethyl chitosan for in vitro release study of methotrexate
293
pH/Temperature control of interpolymer complexation between poly(acrylic acid) and weak polybases in aqueous solutions
294
pH/temperature sensitive poly(ethylene glycol)-based biodegradable polyester block copolymer hydrogels
295
pH/temperature-responsive behaviors of semi-IPN and comb-type graft hydrogels composed of alginate and poly(N-isopropylacrylamide)
296
pH/temperature-sensitive 4-arm poly(ethylene glycol)-poly(amino urethane) copolymer hydrogels
297
Ph[PhC(O)NH]2PyNC(O)Ph: a new mesomeric stabilized azaylide. Synthesis, crystal structure and IR spectroscopic results
298
Ph[PhC(O)NH]2PyNC(O)Ph: a new mesomeric stabilized azaylide. Synthesis, crystal structure and IR spectroscopic results
299
Ph3BiCO3: a mild reagent for in situ oxidation of urazoles to triazolinediones
300
Ph3P/Br2/n-Bu4NNO2 as an efficient system for the preparation of N-nitrosamines and azides
301
PHA based denitrification: Municipal wastewater vs. acetate
302
PHA immune response assay in captive zebra finches is modulated by activity prior to testing
303
PHA production by mixed cultures: A way to valorize wastes from pulp industry
304
PHA production from wastewater by mixed microbial culture under short-term microbial enrichment
305
PHA stimulation may be useful for FDXR gene expression-based biodosimetry
306
PHA/IL2: An Efficient Mitogen Cocktail for Cytogenetic Studies of Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
307
PHA: A fast potential-based hierarchical agglomerative clustering method
308
PHAC SYNTHASES AND PHA DEPOLYMERASES: THE ENZYMES THAT PRODUCE AND DEGRADE PLASTIC
309
PHACE(S) syndrome: Report of a case with new ocular and systemic manifestations
310
PHACES (Photographs of Academic Clinicians and Their Educational Status): A Tool to Improve Delivery of Family-Centered Care
311
PHACES syndrome with cataract and Horner’s syndrome: a case report
312
Phaco chop: Matering technique, optimizing technology, and avoiding complication
313
Phacodynamic: An Apiration Flow v Vacuum Comparion
314
Phacodynamic: Matering the Tool and Technique of Phacoemulification urgery; Fourth Edition
315
Phacoemulification and len implantation after cleral buckling urgery
316
Phacoemulification Aociated Corneal Damage Evaluated by Corneal Volume
317
Phacoemulification cataract extraction and poterior chamber len implantation in patient with uveiti
318
Phacoemulification of Cataract in Patient Receiving Coumadin Therapy: Ocular and Hematologic Rik Aement Original Reearch Article
319
Phacoemulification v mall-Inciion Manual Cataract urgery: An Expert Trial
320
Phacoemulsification of bilateral cataracts in two pet rabbits
321
Phacomorphic Glaucoma as the First Manifestation of the Choroidal Malignant Melanoma
322
Phacotrabeculectomy and Implantation of Intraocular Lenses with Releasable Sutures and Antimetabolite Agents: Efficacy and Safety
323
Phacotrabeculectomy With Mitomycin C in Patient With Uveiti
324
Phae I/II randomized trial of intrahepatic arterial infuion chemotherapy with ciplatin and chemoembolization with ciplatin and polyvinyl ponge in patient with ocular melanoma metatatic to the liver
325
Phaehyphomycosis caused by Veronea bothryosa
326
Phaeoacremonium tuscanicum, a new fungal pathogen associated with oak decline in Zagros forests, Iran
327
Phaeochromocytoma
328
Phaeochromocytoma—views on current management
329
Phaeocystis blooms in the global ocean and their controlling mechanisms: a review
330
Phaeohyphomycosis caused by Diaporthe phaseolorum in an immunocompetent patient in Thailand: a case report
331
Phaeomoniella chlamydospora: causal agent of vine decline (Vitis vinifera) in the vineyards of Slovakia
332
Phaeophytins from Gossypium mustelinum Miers ex Watt (Malvaceae)
333
Phage adsorption to Lactobacillus plantarum: Influence of physiological and environmental factors
334
Phage coated magnetoelastic micro-biosensors for real-time detection of Bacillus anthracis spores
335
Phage Display and Crystallographic Analysis Reveals Potential Substrate/Binding Site Interactions in the Protein Secretion Chaperone CsaA from Agrobacterium tumefaciens
336
Phage display as a tool for the directed evolution of enzymes
337
Phage display combinatorial libraries of short peptides: ligand selection for protein purification
338
Phage display identifies an Eastern equine encephalitis virus glycoprotein E2-specific B cell epitope
339
Phage display identifies an Eastern equine encephalitis virus glycoprotein E2-specific B cell epitope
340
Phage display of functional, full-length human and viral membrane proteins
341
Phage Display Reveals Multiple Contact Sites between FhuA, an Outer Membrane Receptor of Escherichia coli, and TonB
342
Phage Display Screening Reveals an Association Between Germline-specific Transcription Factor Oct-4 and Multiple Cellular Proteins
343
Phage display selection and characterization of single-chain recombinant antibodies against Eimeria tenella sporozoites
344
Phage display selection and characterization of single-chain recombinant antibodies against Eimeria tenella sporozoites
345
Phage display techniques to obtain antibodies against turbot (Scophthalmus maximus) blood cells
346
Phage display technology for stem cell delivery and systemic therapy
347
Phage display technology: clinical applications and recent innovations
348
Phage FR38 Treatment on Sprague Dawley Rat Inferred from Blood Parameters and Organ Systems
349
Phage Genomics: Small Is Beautiful
350
Phage inactivation of foodborne pathogens on cooked and raw meat
351
Phage inactivation of Staphylococcus aureus in fresh and hard-type cheeses
352
Phage Integrases: Biology and Applications Review Article
353
Phage Langmuir monolayers and Langmuir–Blodgett films
354
Phage Like It HOT: Solution Structure of the Bacteriophage P1-Encoded HOT Protein, a Homolog of the θ Subunit of E. coli DNA Polymerase III
355
Phage ø29 DNA polymerase residues involved in the proper stabilisation of the primer-terminus at the 3′-5′ exonuclease active site
356
Phage P22 Procapsids Equilibrate with Free Coat Protein Subunits
357
Phage Peptide Libraries As a Source of Targeted Ligands
358
Phage selection for site-specific incorporation of unnatural amino acids into proteins in vivo Original Research Article
359
Phage Therapy in COVID-19 Treatment
360
Phage therapy: A modern tool to control bacterial infections
361
Phage therapy: assessment of the efficacy of a bacteriophage isolated in the treatment of salmonellosis induced by Salmonella enteritidis in mice
362
Phage therapy—advantages over antibiotics?
363
Phage Types of multidrug resistant Salmonella species in a rural area of Maharashtra, India
364
Phage types, virulence genes and PFGE profiles of Shiga toxin-producing Escherichia coli O157:H7 isolated from raw beef, soft cheese and vegetables in Lima (Peru)
365
Phage typing combined with pulsed-field gel electrophoresis and random amplified polymorphic DNA increases discrimination in the epidemiological analysis of Salmonella enteritidis strains
366
Phage typing, PCR amplification for mecA gene, and antibiotic resistance patterns as epidemiologic markers in nosocomial outbreaks of methicillin resistant Staphylococcus aureus
367
Phage versus Phagemid Libraries for Generation of Human Monoclonal Antibodies
368
Phage λ takes the first exit
369
Phage-based nanomaterials for biomedical applications
370
Phage-borne peptidomimetics as immunochemical reagent in dot-immunoassay for mycotoxin zearalenone
371
Phage-displayed Antibody Libraries of Synthetic Heavy Chain Complementarity Determining Regions
372
Phage-displayed peptide library screening for preferred human substrate peptide sequences for transglutaminase 7
373
Phage-displayed peptides that mimic zearalenone and its application in immunoassay
374
Phage-displayed protein chip based on SPR sensing
375
Phagemid Vectors for Phage Display: Properties, Characteristics and Construction Review Article
376
Phage-peptide Display Identifies the Interferon-responsive, Death-activated Protein Kinase Family as a Novel Modifier of MDM2 and p21WAF1
377
Phage-related DNA polymorphism in dairy and probiotic Lactobacillus
378
Phage-resistance linked to cell heterogeneity in the commercial strain Lactobacillus delbrueckii subsp. lactis Ab1
379
Phage-resistant mutants of Lactobacillus delbrueckii may have functional properties that differ from those of parent strains
380
Phagocyte functions in stressed rats: comparison of modulation by glutamine, arginine and ornithine 2-oxoglutarate
381
Phagocyte implications in advanced atherosclerosis
382
Phagocyte-derived S100 proteins in autoinflammation: Putative role in pathogenesis and usefulness as biomarkers
383
Phagocyte-Generated Superoxide Reduces Fe3+ to Displace It from the Surface of Asbestos
384
Phagocyte-induced lipid peroxidation of different intravenous fat emulsions and counteractive effect of vitamin E
385
Phagocyte–myocyte interactions and consequences during hypoxic wound healing
386
Phagocytes and oxidative stress
387
Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules
388
Phagocytic Activity and IL-1 Alpha Levels for Asthma Patients
389
Phagocytic activity of alveolar macrophages toward polystyrene latex microspheres and PLGA microspheres loaded with anti-tuberculosis agent
390
Phagocytic Activity of Patients with a Diabetic Foot in Wasit Province, Iraq
391
Phagocytic activity of scallop (Pecten maximus) haemocytes maintained in vitro
392
Phagocytic activity of turbot (Scophthalmus maximus) leucocytes: opsonic effect of antibody and complement
393
Phagocytic activity of two lines of chickens divergently selected for antibody production
394
Phagocytic activity of two lines of chickens divergently selected for antibody production
395
Phagocytic and chemotactic responses of manila and carpet shell clam haemocytes against Vibrio tapetis, the causative agent of brown ring disease
396
Phagocytic and Metabolic Activities of Macrophages from Mummichog Naturally Exposed to Pulp Mill Effluents in the Miramichi River
397
Phagocytic capacity and apoptosis of peripheral blood cells from patients with iron deficiency anemia
398
Phagocytic cells of the thymic reticulum interact with thymocytes via extracellular matrix ligands and receptors
399
Phagocytic function and metabolite production in thioacetamide-induced liver cirrhosis: a comparative study in perfused livers and cultured Kupffer cells
400
Phagocytic killing of microorganisms by radical processes:consequences of the reaction of hydroxyl radicals with chloride yielding chlorine atoms
401
Phagocytic response of macrophages from the pronephros of American plaice (Hipoglossoides platessoides) exposed to contaminated sediments from Baie des Anglais, Quebec
402
Phagocytic Response of Terrestrial and Aquatic Invertebrates Following in Vitro Exposure to Trace Elements
403
Phagocytosis and development: back to the future
404
Phagocytosis and innate immunity
405
Phagocytosis and respiratory burst activity of haemocytes from the ivory snail, Babylonia areolata
406
Phagocytosis by B-cells and neutrophils in Atlantic salmon (Salmo salar L.) and Atlantic cod (Gadus morhua L.)
407
Phagocytosis in pup and adult harbour, grey and harp seals
408
Phagocytosis in pup and adult harbour, grey and harp seals
409
Phagocytosis inhibition of clam and mussel haemocytes by Perkinsus atlanticus secretion products.
410
Phagocytosis of Candida albicans by concanavalin-A activated peritoneal macrophages
411
Phagocytosis of Candida albicans by concanavalin-A activated peritoneal macrophages
412
Phagocytosis of candida albicans by lymphatic tumour cells in vitro
413
Phagocytosis of Candida albicans by metastatic and non metastatic human breast cancer cell lines in vitro
414
Phagocytosis of chemically modified carbon materials
415
Phagocytosis of Loma salmonae (Microsporidia) spores in Atlantic salmon (Salmo salar), a resistant host, and chinook salmon (Oncorhynchus tshawytscha), a susceptible host
416
Phagocytosis of N-acetyl-d-glucosamine particles, a Th1 adjuvant, by RAW 264.7 cells results in MAPK activation and TNF-α, but not IL-10, production
417
Phagocytosis of wear debris by osteoblasts affects differentiation and local factor production in a manner dependent on particle composition
418
Phagocytosis, endosomal/lysosomal system and other cellularaspects of macrophage activation by Canova medication
419
Phagocytotic removal of apoptotic endocrine cells by folliculostellate cells and its functional implications in clusterin accumulation in pituitary colloids in helmeted guinea fowl (Numida meleagris)
420
Phagostimulatory effect of uptake of PLGA microspheres loaded with rifampicin on alveolar macrophages
421
Phagotrophic algae in a wastewater stabilization pond
422
PHAHs in 14 principal river sediments from Hai River basin, China Original Research Article
423
Phakic Intraocular Lenses and their Special Indications
424
Phakic IOL: A photo finih?
425
Phakic poterior chamber intraocular len for the correction of aniometropia and treatment of amblyopia
426
Phakomatosis pigmentovascularis type IIa
427
Phalangeal osteochondroma: a cause of childhood trigger finger
428
Phalangeal osteosonogrammetry age-related changes and assessment of a Lebanese reference population
429
Phalangeal Tuberculosis After Mallet Finger Treatment: A Case Report
430
Phalangeal ultrasonography in forearm fracture discrimination
431
Phalanx-like osseous structure posterior to the cervical vertebrae: a hitherto unreported location for a rare anomaly
432
Phalaropes feeding at a coastal front in Santa Monica Bay, California
433
PHALEN TEST POSITIVATION TIME and ITS CORRELATION WITH ELECTRONEUROMYOGRAPHY
434
Phallometric testing with sexual offenders: Limits to its value
435
Phalloplasty for an amputated phallus in intersex patients
436
Phalloplasty in female-to-male transsexuals using free radial osteocutaneous flap: a series of 22 cases, ,
437
Phanerochaete chrysosporium pretreatment of biomass to enhance solvent production in subsequent bacterial solid-substrate cultivation
438
Phanerochaete flavido-alba ligninolytic activities and decolorization of partially bio-depurated paper mill wastes
439
Phanerozoic atmospheric CO2 change: evaluating geochemical and paleobiological approaches
440
Phanerozoic biodiversity: rocks or real?
441
Phanerozoic burial and unroofing history of the western Slave craton and Wopmay orogen from apatite (U–Th)/He thermochronometry
442
Phanerozoic changes in the high-rank suprageneric diversity structure of brachiopods: Linear and non-linear effects
443
Phanerozoic continental growth and gold metallogeny of Asia
444
Phanerozoic Continental Growth of East and Southeast Asia: Timings of Amalgamation and Accretion
445
Phanerozoic Geodynamic Evolution of the Circum-Italian Realm
446
Phanerozoic high-pressure eclogite and intermediate-pressure granulite facies metamorphism in the Gyeonggi Massif, South Korea: Implications for the eastward extension of the Dabie–Sulu continental collision zone
447
Phanerozoic hot spot traces and paleogeographic reconstructions of the Siberian continent based on interaction with the African large low shear velocity province
448
Phanerozoic Large Igneous Provinces (LIPs), HEATT (Haline Euxinic Acidic Thermal Transgression) episodes, and mass extinctions
449
Phanerozoic marine biodiversity follows a hyperbolic trend
450
Phanerozoic organic-carbon-rich marine sediments: Overview and future research challenges
451
Phanerozoic paleogeography, paleoenvironment and lithofacies maps of the circum-Atlantic margins
452
Phanerozoic polar wander, palaeogeography and dynamics
453
Phanerozoic reactivation along a fundamental Proterozoic crustal fault, the Darling River Lineament, Australia: constraints from apatite fission track thermochronology
454
Phanerozoic reactivation of the Archean North China Craton through episodic magmatism: Evidence from zircon U–Pb geochronology and Hf isotopes from the Liaodong Peninsula
455
Phanerozoic Reconstitution of Indian Shield as Aftermath of Gondwana Break-up
456
Phanerozoic tectonics of the South China Block: Key observations and controversies
457
Phanerozoic tectonothermal events of the Xuefengshan Belt, central South China: Implications from UPb age and LuHf determinations of granites
458
Phanerozoic, pre-Cretaceous thermotectonic events in southern Sweden revealed by fission track thermochronology
459
Phanerozoic, pre-Cretaceous thermotectonic events in southern Sweden revealed by fission track thermochronology
460
Phanquinone: a useful fluorescent pre-chromatographic derivatization reagent for liquid chromatographic analyses of amino acid dosage forms Original Research Article
461
PHANTASTICA Regulates Development of the Adaxial Mesophyll in Nicotiana Leaves
462
Phantom accretion by black holes and the generalized second law of thermodynamics
463
Phantom and in vivo study of the look–locher T1 mapping method
464
Phantom Archean crust in Mangaia hotspot lavas and the meaning of heterogeneous mantle
465
Phantom bursting is highly sensitive to noise and unlikely to account for slow bursting in -cells: Considerations in favor of metabolically driven oscillations
466
Phantom dosimeters examined by NMR analysis: a promising technique for 3-D determination of absorbed dose
467
Phantom elasticity reconstruction with Digital Image Elasto-Tomography
468
Phantom endometriosis of the sciatic nerve
469
Phantom evolution in power-law potentials Original Research Article
470
Phantom faces for face analysis
471
Phantom feelings in the thalamus explained
472
Phantom Friedmann cosmologies and higher-order characteristics of expansion
473
Phantom limb after stroke: An underreported phenomenon
474
Phantom limb pain
475
Phantom limb pain
476
Phantom limb pain in pediatric burn survivors
477
Phantom Limb Sensation (PLS) and Phantom Limb Pain (PLP) among Young Landmine Amputees
478
PHANTOM LIMB SYNDROME: A REVIEW
479
Phantom limbs – Or phantoms of phantom limbs?
480
Phantom maps and homology theories
481
Phantom Maps and Purity in Modular Representation Theory, III
482
Phantom maps and the Gray index
483
Phantom Maps in the Stable Module Category
484
Phantom materials for single point imaging pulse sequences
485
Phantom nurses at real bedsides
486
Phantom recall
487
Phantom reflexes: Muscle contractions at a frequency not physically present in the input stimuli
488
Phantom study of radiotracer concentration quantification in breast scintigraphy
489
Phantom thermodynamics Original Research Article
490
Phantom tumor of the lung in heart failure patient
491
Phantom Validation of Tc-99m Absolute Quantification in a SPECT/CT Commercial Device
492
PHANTOM: A Monte Carlo event generator for six parton final states at high energy colliders Original Research Article
493
Phantom: a simple and effective flow control scheme
494
Phantom-based performance evaluation: Application to brain segmentation from magnetic resonance images
495
Phantom-like behaviour in dilatonic brane-world scenario with induced gravity Original Research Article
496
Phantom-limb lengthening after heart transplant
497
Phantom-limb pain: characteristics, causes, and treatment
498
Phantom-node method for shell models with arbitrary cracks
499
Phantoms and spectres: capital and labour at the millennium
500
Phantoms of regularity in the sea of quantum chaos
501
PhAP protease from Pseudoalteromonas haloplanktis TAC125: Gene cloning, recombinant production in E. coli and enzyme characterization
502
Phar Lap and duodenitis-proximal jejunitis
503
Pharaoh and the Divine Wont of Respiting: A Critical Analysis of Quranic Themes
504
PHARAOH EAGLE-OWL BUBO ASCALAPHUS (SAVIGNY, 1809) (STRIGIFORMES, STRIGIDAE), THE “SHROUDED IN MYSTERY” OWL OF IRAQ and IRAN
505
Pharmaceutical Advances and Proteomics Researches
506
Pharmaceutical advertising versus research spending: are profits more important than patients?
507
Pharmaceutical analysis of 5-aminolevulinic acid in solution and in tissues
508
Pharmaceutical Analysis, D.C. Lee, M. Webb (Eds.). Blackwell Publishing Ltd, Oxford, UK (2003)
509
Pharmaceutical and Bio-analytical Applications of Ion Mobility Spectrometry for Determination of Clopidogrel (Plavix)
510
Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy
511
Pharmaceutical and clinical aspects of p-phenylene-diamine patch test material
512
PHARMACEUTICAL AND CLINICAL EVALUATION OF INTRAVENOUS ADMIXTURE OF DOBUTAMINE AND DOPAMINE USED IN TREATMENT HYPOTENSION IN NEONATAL INTENSIVE CARE UNITS
513
Pharmaceutical and industrial protein engineering: Where we are?
514
Pharmaceutical and nutraceutical effects of Pinus pinaster bark extract
515
Pharmaceutical and nutraceutical management of canine osteoarthritis: Present and future perspectives
516
Pharmaceutical and personal care products (PPCPs) in urban receiving waters l
517
Pharmaceutical and personal care products in tile drainage following surface spreading and injection of dewatered municipal biosolids to an agricultural field Original Research Article
518
Pharmaceutical and Related Drugs
519
Pharmaceutical applications of a flurbiprofen sensor
520
Pharmaceutical applications of calorimetric measurements in the new millennium
521
Pharmaceutical applications of confocal laser scanning microscopy: The physical characterisation of pharmaceutical systems
522
Pharmaceutical applications of dynamic mechanical thermal analysis
523
Pharmaceutical applications of embryonic stem cells
524
Pharmaceutical applications of isoelectric focusing on microchip with imaged UV detection
525
Pharmaceutical applications of magnetic resonance imaging (MRI)
526
Pharmaceutical applications of Mid-IR and Raman spectroscopy
527
Pharmaceutical applications of some spanish clays (sepiolite, palygorskite, bentonite): some preformulation studies
528
Pharmaceutical applications of various natural gums, mucilages and their modified forms
529
Pharmaceutical Approaches and Advancements in Male Contraception
530
Pharmaceutical aspects of parenteral nutrition: from now to the future
531
Pharmaceutical Care Approach to Hearing Loss
532
Pharmaceutical Care Education and Practice in Jordan in the New Millennium
533
Pharmaceutical care impact on health-related quality of life (HRQOL) and pharmaco-economical burden on COVID recovered diabetic patients with comorbid condition
534
Pharmaceutical Care Program for Patients With Uncontrolled Hypertension: Report of a Double-Blind Clinical Trial With Ambulatory Blood Pressure Monitoring
535
Pharmaceutical challenges in veterinary product development
536
Pharmaceutical Characterization and in vivo Evaluation of the Possible Anti-Inflammatory Effect of Topical Allopurinol Gel in an Animal Model
537
Pharmaceutical Characterization of Aqueous Stem Bark Extract of Bridelia ferruginea Benth (Euphorbiaceae)
538
Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment
539
Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation
540
Pharmaceutical Co-Crystallization: Regulatory Aspects, Design, Characterization, and Applications
541
Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development
542
Pharmaceutical companies and the third world
543
Pharmaceutical companies pay criminal fine for fxobal price fixing
544
Pharmaceutical companies pledge vaccines for developing countries
545
Pharmaceutical companies target plant products for drugs of the future
546
Pharmaceutical company trials and the integrity of medical research
547
Pharmaceutical Compounds as Photostabilizers
548
Pharmaceutical cost management and access to psychotropic drugs: The U.S. context
549
Pharmaceutical economy and the economic assessment of drugs in France
550
Pharmaceutical Electrochemistry: the Electrochemical Behaviour of Paracetamol at ZnO Nanoparticales/1, 2-Napthaquinone-4-Sulphonic Acid Glassy Carbon Modified Electrode
551
Pharmaceutical Equivalence of Some Commercial Samples of Artesunate and Amodiaquine Tablets Sold in Southwestern Nigeria
552
Pharmaceutical Evaluation of Metformin HCl Products Available in the Jordanian Market
553
Pharmaceutical Evaluation of Ziziphus Jujuba Mucoadhesive Buccal Film
554
Pharmaceutical Excipient Development: The Need for Preclinical Guidance
555
Pharmaceutical Formulation of Garlic and Turmeric Dried Crude Extract and Their Synergistic Antifungal Activity and Safety
556
Pharmaceutical haute couture: educating patients about health-care choices
557
Pharmaceutical impurities: Analytical, toxicological and regulatory perspectives
558
Pharmaceutical impurities: Regulatory perspective for Abbreviated New Drug Applications
559
Pharmaceutical industry profits and cost to senior citizensʹ health
560
Pharmaceutical Industry Roundtable Abstracts
561
Pharmaceutical innovation and longevity growth in 30 developing and high-income countries, 2000–2009
562
Pharmaceutical laws and regulations in Iran: An overview
563
Pharmaceutical microcalorimetry: recent advances in the study of solid state materials
564
Pharmaceutical Nanoemulsions and Their Potential Topical and Transdermal Applications
565
Pharmaceutical Nanoparticles and the Mucin Biopolymer Barrier
566
Pharmaceutical nanotechnology for oral delivery of anticancer drugs
567
Pharmaceutical Nickel(II) Chelation Properties of 3-Hydroxyflaven, Deferiprone and Maltol Metal Chelators: A Density Functional Study
568
Pharmaceutical patent analyst – FutureScience publishing
569
Pharmaceutical patents on plant derived materials in Brazil: Policy, law and statistics
570
Pharmaceutical policies used by private health insurance companies in Saudi Arabia
571
Pharmaceutical powder technology — from art to science: the challenge of the FDAʹs Process Analytical Technology initiative
572
Pharmaceutical powders analysis using FT-Raman spectrometry: Simultaneous determination of sulfathiazole and sulfanilamide
573
Pharmaceutical powders compaction: Experimental and numerical analysis of the density distribution
574
pharmaceutical prescription (Rx): Calcium, phosphate, and secundum artem
575
Pharmaceutical profiling method for lipophilicity and integrity using liquid chromatography–mass spectrometry
576
Pharmaceutical Properties of Hibiscus sabdariffa, Toward an Ideal Treatment for Hypertension
577
Pharmaceutical reform and physician strikes in Korea: separation of drug prescribing and dispensing
578
Pharmaceutical representatives
579
Pharmaceutical representatives’ beliefs and practices about their professional practice: a study in Sudan
580
Pharmaceutical Research in Wilhelmine Germany: The Case of E. Merck
581
Pharmaceutical research: paradox, challenge or dilemma?
582
Pharmaceutical risk management in Turkey: The first national overview
583
Pharmaceutical Statistics Using SAS®: A Practical Guide by Alex Dmitrienko, Christy Chuang-Stein, Ralph DʹAgostino
584
Pharmaceutical strategic purchasing requirements in Iran: Price interventions and the related effective factors
585
Pharmaceutical Strategic Purchasing: a Key to Improve Access to Medicines
586
Pharmaceutical supply chain risks: a systematic review
587
Pharmaceutical toxicology: Designing studies to reduce animal use, while maximizing human translation
588
Pharmaceutical trace analysis in aqueous environmental matrices by liquid chromatography–ion trap tandem mass spectrometry
589
Pharmaceutical Wastewater Chemical Oxygen Demand Reduction: Electro-Fenton, UV-enhanced Electro-Fenton and Activated Sludge
590
Pharmaceutical wastewater treatment by membrane bioreactor process – a case study in southern Taiwan Original Research Article
591
Pharmaceutical workers
592
PHARMACEUTICAL, FOOD AND NON-FOOD APPLICATIONS OF MODIFIED STARCHES: A CRITICAL REVIEW
593
Pharmaceutical-enantiomers resolution using immobilized polysaccharide-based chiral stationary phases in supercritical fluid chromatography
594
Pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) in stormwater canals and Bayou St. John in New Orleans, Louisiana, USA
595
Pharmaceuticals and personal care products (PPCPs) in foods. Potential risks to human health?
596
Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada
597
Pharmaceuticals and personal care products (PPCPs) in treated wastewater discharges into Charleston Harbor, South Carolina Original Research Article
598
Pharmaceuticals and the Strategic National Stockpile Program
599
Pharmaceuticals in Australia: developments in regulation and governance
600
Pharmaceuticals in groundwaters: Analytical methods and results of a monitoring program in Baden-Württemberg, Germany
601
PHARMACEUTICALS IN IRAN: AN OVERVIEW
602
Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment
603
Pharmaceuticals in the aquatic environment––a comparison of risk assessment strategies
604
Pharmaceuticals in the river Elbe and its tributaries
605
Pharmaceuticals Safety Practices-A Comparative Pilot Study
606
Pharmaceuticals Solubility is Still Nowadays Widely Studied Everywhere
607
Pharmaceuticals, alkylphenols and pesticides in Mediterranean coastal waters: Results from a pilot survey using passive samplers
608
Pharmaceuticals, hormones and bisphenol A in untreated source and finished drinking water in Ontario, Canada — Occurrence and treatment efficiency Original Research Article
609
Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: A proposed ranking system Original Research Article
610
Pharmaceuticals: a threat to drinking water? Original Research Article
611
Pharmaceuticals—our true clinical partners?
612
Pharmaciesʹ over-the-counter drug monopoly in Denmark ended
613
Pharmacies, self-medication and pharmaceutical marketing in Bombay, India
614
Pharmacist and nurse: a team approach towards primary health care or a convenient “therapeutic alliance”? Original Research Article
615
Pharmacist Interventions in Improving Clinical Outcomes in Patients with Type 2 Diabetes Mellitus Among the Underrepresented Population: A Collaborative Ambulatory Care Pharmacy Practice (CAPP) Approach
616
PHARMACIST ROLE IN GLOBAL HEALTH: A REVIEW OF LITERATURE
617
Pharmacist, the pharmaceutical industry and pharmacy education in Saudi Arabia: A questionnaire-based study
618
Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process
619
Pharmacist-Led Medication Review: Supports for New Role of Pharmacists
620
PHARMACIST-MANAGED THERAPEUTIC DRUG MONITORING SERVICE FOR ANTIEPILEPTIC DRUGS AND IMPROVED SEIZURE CONTROL
621
Pharmacist-Physician Organic Cooperation Is an Effective Strategy to Reduce the Medication-related Problems, An Experience in CKD Patients
622
Pharmacists agree: stop the pharmacy madness
623
Pharmacists as Entrepreneurs or Employees: The Role of Locus of Control
624
Pharmacists Remuneration Models in Iran and Selected Countries: a Comparative Study
625
PHARMACISTS UNDERSTANDING AND ATTITUDES TOWARDS PHARMACEUTICAL CARE IN SAUDI ARABIA
626
Pharmacists’ and physicians’ perception and exposure to drug promotion: A Saudi study
627
Pharmacists’ Attitudes and Perceived Barriers about Community Pharmacy-Based Cardiovascular Risk Screening Services
628
PHARMACISTS’ NEGLIGENCE AND PRINCIPLES OF LIABILITY
629
Pharmacists’ Perception of the Sale of Non-Clinically Proven Health Supplements in Penang, Malaysia
630
Pharmaco1logic Evaluation of the Calcitonin Analogue SB 205614 in Models of Osteoclastic Bone Resorption In Vitro and In Vhro: Comparison With Salmon Calcitonin and Elcatonin
631
Pharmacodynamic activity of lipoprotein lipase and hepatic lipase, and pharmacokinetic parameters measured in normolipidaemic subjects receiving ciprofibrate (100 or 200 mg/day) or micronised fenofibrate (200 mg/day) therapy for 23 days
632
Pharmacodynamic and/or pharmacokinetic characteristics of interactions between loreclezole and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: An isobolographic analysis
633
Pharmacodynamic Effect of N-Acetylcysteine as Adjunctive Therapy in Mild Systemic Lupus Erythematosus Patients
634
Pharmacodynamic effects of milrinone with and without a bolus loading infusion
635
Pharmacodynamic Effects of Prasugrel Dosing Regimens in Patients on Maintenance Prasugrel Therapy: Results of a Prospective Randomized Study
636
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Patients With Stable Coronary Artery Disease: Results of the SWAP-2 Study (Switching Anti Platelet-2)
637
PHARMACODYNAMIC INTERACTION OF GARLIC WITH PROPRANOLOL IN ISCHEMIA-REPERFUSION INDUCED MYOCARDIAL DAMAGE
638
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects Original Research Article
639
Pharmacodynamic interactions of amodiaquine and its major metabolite desethylamodiaquine with artemisinin, quinine and atovaquone in Plasmodium falciparum in vitro
640
Pharmacodynamic profile of short-term readministration of abciximab in healthy subjects
641
Pharmacodynamic profile of the direct thrombin antagonist bivalirudin given in combination with the glycoprotein IIb/IIIa antagonist eptifibatide
642
Pharmacodynamic profiling of levofloxacin and gatifloxacin using Monte Carlo simulation for community-acquired isolates of Streptococcus pneumoniae
643
Pharmacodynamic study on acute hypotensive activities of Carissa carandas extract in normal rats
644
Pharmacodynamic–pharmacokinetic profiles of metformin hydrochloride from a mucoadhesive formulation of a polysaccharide with antidiabetic property in streptozotocin-induced diabetic rat models
645
Pharmacodynamics and microbiology of trovafloxacin in animal models of surgical infection
646
Pharmacodynamics and pharmacokinetics of cefoperazone and cefamandole in dogs following single dose intravenous and intramuscular administration
647
Pharmacodynamics and pharmacokinetics of flumequine in pigs after single intravenous and intramuscular administration
648
Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: Comparison with single and multiple daily doses of ilgrastim
649
Pharmacodynamics in the elderly
650
Pharmacodynamics of alpha2-adrenoceptor agonists
651
Pharmacodynamics of antimicrobial therapy in surgery
652
Pharmacodynamics of immunosuppressive drugs
653
Pharmacodynamics of Intermittent- and Continuous-Infusion Gefepime Alone and in Combination with Once-Daily Tobramycin against Pseudomonas aeruginosa in an in vitro Infection Model
654
Pharmacodynamics of mivacurium in severely burned patients
655
Pharmacodynamics of warfarin in cats
656
Pharmacodynamics Studies on Ricobendazole In Male Rats
657
Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia
658
Pharmacodynamics: Relation to Antimicrobial Resistance
659
Pharmacodynamics: Relation to antimicrobial resistance
660
Pharmacoeconomic Aspects of Treating Hemorrhoidal Disease-Cost of Illness Study Based on Data from Balkan Country with Recent History of Social and Economic Transition
661
Pharmacoeconomic assessment of midazolam in two emergency departments
662
Pharmacoeconomic Education for Pharmacy Students in Bosnia and Herzegovina
663
Pharmacoeconomic Evaluation of Anti-Diabetic Therapy in A Nigerian Tertiary Health Institution
664
Pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes
665
Pharmacoeconomic Impact Evaluation of Statin Adherence in High-risk Unselected Post Myocardial Infarction Population: an Administrative Database-guided Analysis
666
Pharmaco-economic issues for diabetes therapy
667
Pharmacoeconomic issues in antihypertensive therapy
668
Pharmacoeconomic study of antibiotics used in the treatment of lower respiratory tract infections in ICU patients: A case study in an Egyptian hospital
669
Pharmacoeconomics Analysis in a Pediatric Population
670
Pharmaco-economics analysis, as a strategy on facilitating choices between health and non-health programs in the establishment of the national health care system
671
Pharmacoeconomics and health outcomes: state of the art
672
Pharmacoeconomics and Utilization of Intravenous Iron Sucrose in a Tertiary Care Hospital
673
Pharmacoeconomics and Utilization of Intravenous Proton Pump Inhibitors in a Tertiary Care Hospital
674
Pharmacoeconomics for surgeons
675
Pharmacoeconomics in Iran: It Is Time to Take It into Practice
676
Pharmacoeconomics of Angiotensin Converting Enzyme Inhibitors in Heart Failure
677
PHARMACO-ECONOMICS OF MICRODOSING CLINICAL TRIALS IN DRUG DEVELOPMENT PROCESS
678
Pharmacoeconomics of pneumonia
679
Pharmacoeconomics: what is it and where is it going?
680
Pharmacoeconomics; an Appropriate Tool for Policy Makers or Just a New Field of Research in Iran?
681
Pharmaco-EEG-based assessment of interaction between ethanol and levetiracetam
682
Pharmacoepidemiological study of self-medication in adults attending pharmacies in Alexandria, Egypt
683
Pharmacoepidemiology of Drugs Used in Indoor Patients of Orthopaedic Department at a Tertiary Care Hospital
684
Pharmacoepidemiology Safety Study of Fibrate and Statin Concomitant Therapy
685
Pharmacogenetic Effect of Thiopurine Methyl Transferase (TPMT) Gene Expression and Serum TNF on the Imuran Response in Ulcerative Colitis (UC) Iraqi Patients
686
Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure Original Research Article
687
Pharmacogenetic prediction of clozapine response Original Research Article
688
Pharmacogenetic Studies of Depression
689
Pharmacogenetic Testing for Warfarin Dosing Still Awaits Validation
690
Pharmacogenetic variation of SLC47A1 gene and metformin response in type2 diabetes patients
691
Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450–metabolized drugs
692
Pharmacogenetics and adverse drug reactions
693
Pharmacogenetics and antipsychotic drugs
694
Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients
695
Pharmacogenetics and future drug development and delivery
696
Pharmacogenetics and Personalized Medicine in Pancreatic Cancer
697
Pharmacogenetics draws an ACE
698
Pharmacogenetics in Cardiovascular Antithrombotic Therapy
699
Pharmacogenetics of anti-estrogen treatment of breast cancer
700
Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine
701
Pharmacogenetics of clozapine response
702
Pharmacogenetics of CYP enzymes and drug transporters: remarkable recent advances
703
Pharmacogenetics of disease-modifying anti-rheumatic drugs
704
Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management
705
Pharmacogenetics of inflammatory bowel disease
706
Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother
707
Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
708
Pharmacogenetics, the Promise of Translating Personalized Medicine into Clinical Pediatrics
709
Pharmacogenetics: Fitting the Drug to the Patient
710
Pharmacogenetics: Is the right drug for the right patient sufficient?
711
Pharmacogenetics: Yeast Lead the Way
712
Pharmacogenetics-Oriented Therapeutic Drug Monitoring of Digoxin in Critically ILL Patients
713
Pharmacogenetics-Oriented Therapeutic Drug Monitoring of Digoxin in Critically ILL Patients
714
Pharmacogenomic approaches in the treatment of breast cancer by tamoxifen
715
Pharmacogenomic determination of genes associated with sensitivity or resistance of tumor cells to curcumin and curcumin derivatives
716
Pharmacogenomic profiling of an oxidative stress-mediated spongiform encephalopathy
717
Pharmacogenomic Profiling of the PI3K/PTEN Pathway in Sporadic Breast Cancer
718
Pharmacogenomics and -genetics in colorectal cancer
719
Pharmacogenomics and the Failing Heart: Are We Waiting for Godot?
720
Pharmacogenomics for Infectious Diseases
721
pharmacogenomics implementation and hurdles to overcome; in the context of a developing country
722
Pharmacogenomics in bladder cancer
723
Pharmacogenomics in bladder cancer
724
Pharmacogenomics in Cancer Chemotherapy
725
Pharmacogenomics in cancer drug discovery and development: inhibitors of the Hsp90 molecular chaperone
726
Pharmacogenomics in non-small-cell lung cancer chemotherapy
727
Pharmacogenomics of organic anion-transporting polypeptides (OATP)
728
Pharmacogenomics- The Promise of Personalized Medicine
729
Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs
730
Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs
731
Pharmacogenomics: out of the lab and into the community
732
Pharmacognostic and Acute Toxicity Study of Burkea Africana Root
733
Pharmacognostic and AntiInflammatory Properties of Securigera securidaca Seeds and Seed Oil
734
Pharmacognostic and Elemental Analysis of the Leaves of Tapinanthus globifer (A. Rich). Tiegh
735
Pharmacognostic and Physico-chemical Investigation of Barleria cristata Linn. (Leaf) for Quality Control Assessment
736
Pharmacognostic and phytochemical investigation of Heracleum persicum Desf. ex Fischer
737
Pharmacognostic and Preliminary Phytochemical Investigation on Doronicum scorpioides Roots
738
Pharmacognostic Characteristics and Mutagenic Studies of Alstonia boonei De Wild
739
Pharmacognostic Characteristics of Hibiscus sabdariffa L. as a Means of Monitoring Quality
740
Pharmacognostic evaluation and physico-chemical analysis of Lantana camara (Linn.) flowers
741
Pharmacognostic evaluation of Achyranthes coynei: Leaf
742
Pharmacognostic Evaluation of Maesobotrya barteri (Baill) Hutch and Maesobotrya dusenii Pax (Euphorbiaceae) Leaves
743
Pharmacognostic Evaluation of Oxalis pes-caprae L. (Family Oxalidaceae)
744
Pharmacognostic evaluation of the leaves of Mitracarpus scaber Zucc (Rubiaceae)
745
Pharmacognostic Evaluation of the Leaves of Secamone afzelii (Schult) K Schum (Asclepiadaceae)
746
Pharmacognostic Investigation of the Leaves and Stems of Viburnum erubescens Wall.ex DC
747
Pharmacognostic Profile and Screening of Anti-Proliferative Potential of Methanolic Extract of Tripterygium wilfordii Plant on WRL-68 Cell Line and Function of Polycystin‐1
748
Pharmacognostic Standardization and Chromatographic Fingerprint Analysis on Triterpenoidal Constituents of the Medicinally Important Plant Artocarpus heterophyllus by High‑Performance Thin Layer Chromatography Technique
749
Pharmacognostic study of Argyreia pilosa stem
750
Pharmacognostic, Physicochemical and Phytochemical Investigations on Aerial Parts of Argemone mexicana L.
751
Pharmacognostical and physico-chemical evaluations of Cardiospermum halicacabum L. seeds
752
Pharmacognostical Sources of Popular Medicine To Treat Alzheimer’s Disease
753
Pharmacognostical study of Chorisia insignis HBK. grown in Egypt
754
Pharmacognostical, physico-chemical and contamination studies of polyherbal formulation “qurse pudina”
755
Pharmacokinetic analysis by high-performance liquid chromatography of intravenous nordihydroguaiaretic acid in the mouse
756
Pharmacokinetic analysis in serum of genistein administered subcutaneously to neonatal mice
757
Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography
758
Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging
759
Pharmacokinetic analysis of nicotine when using non-combustion inhaler type of tobacco product in Japanese adult male smokers
760
Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates
761
Pharmacokinetic and drug interaction studies of Pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan
762
Pharmacokinetic and excretion study of three secoiridoid glycosides and three flavonoid glycosides in rat by LC–MS/MS after oral administration of the Swertia pseudochinensis extract
763
Pharmacokinetic and fetal cardiovascular effects of enalaprilat administration to maternal rhesus macaques, ,
764
Pharmacokinetic and Hemodynamic Responses to Oral Sildenafil During Invasive Testing in Children With Pulmonary Hypertension
765
Pharmacokinetic and milk penetration of a difloxacin long-acting poloxamer gel formulation with carboxy-methylcellulose in lactating goats
766
Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part 1. Absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers
767
Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Doseproportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers
768
Pharmacokinetic and Pharmacodynamic Comparison of Controlled-Release Carvedilol and Immediate-Release Carvedilol at Steady State in Patients with Hypertension
769
Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida
770
Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in goats
771
Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation
772
Pharmacokinetic and pharmacodynamic properties of the new AEDs: A review article.
773
Pharmacokinetic and tissue distribution of doxycycline in broiler chickens pretreated with either: Diclazuril or halofuginone
774
Pharmacokinetic and toxicological data of spirolides after oral and intraperitoneal administration
775
Pharmacokinetic and tumour-photosensitizing properties of methoxyphenyl porphyrin derivative
776
Pharmacokinetic applicability of a validated liquid chromatography tandem mass spectroscopy method for orally administered curcumin loaded solid lipid nanoparticles to rats
777
Pharmacokinetic application of fuzzy structure identification and reasoning
778
Pharmacokinetic behavior and pharmacokinetic/pharmacodynamic integration of marbofloxacin after subcutaneous administration in goats
779
Pharmacokinetic behavior of marbofloxacin after intravenous, subcutaneous and intramuscular administrations in llamas (Lama glama)
780
Pharmacokinetic Behavior of Phenytoin in Head Trauma and Cerebrovascular Accident Patients in an Iranian Population
781
Pharmacokinetic Behavior of Theophylline following PEEP in Critically Ill Patients with Acute Lung Injury
782
Pharmacokinetic behaviour of ACP gel, an autocrosslinked hyaluronan derivative, after intraperitoneal administration
783
Pharmacokinetic behaviour of enrofloxacin in greater rheas following a single-dose intramuscular administration
784
Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs
785
Pharmacokinetic comparisons of different combinations of Shaoyao-Gancao-Decoction in rats: Simultaneous determination of ten active constituents by HPLC–MS/MS
786
Pharmacokinetic comparisons of puerarin, daidzin and the glucuronide metabolite of puerarin after administration of total flavonoid from Gegen alone and total flavonoid from Gegen combined with total saponin from Sanqi in rats under different physiologica
787
Pharmacokinetic Computer Simulations of the Relationship Between In Vivo and In Vitro Neuroreceptor Subtype Selectivity of Radioligands
788
Pharmacokinetic considerations for targeted drug delivery
789
Pharmacokinetic differences between ethnic groups
790
Pharmacokinetic differences between ethnic groups
791
Pharmacokinetic dosing of aminoglycosides: a controlled trial
792
Pharmacokinetic Drug Food Interaction Study of Nateglinide and Pomegranate Fruit Juice
793
Pharmacokinetic drug‑drug interaction and their implication in clinical management
794
Pharmacokinetic Effect of MDR Gene Polymorphism rs2032582 on the Therapeutic Response in Iraqi Patients with Acute Myeloid Leukemia
795
Pharmacokinetic enhancement of marbofloxacin by alpha-1-monolaurin pre-treatment in broiler chickens
796
PHARMACOKINETIC EVALUATION OF CLARITHROMYCIN ORAL CONTROLLED RELEASE MATRIX TABLETS FOR DESIRED BIOAVAILABILITY AND IMPROVED PATIENT COMPLIANCE
797
Pharmacokinetic evaluation of dipfluzine and its three metabolites in rat plasma using liquid chromatography–mass spectrometry
798
Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug
799
Pharmacokinetic evaluation of tramadol and its major metabolites after single oral sustained tablet administration in the dog: a pilot study
800
Pharmacokinetic Evaluation of Two Doses of Aminophylline/Theophylline Administered as Multiple Intermittent Infusions to Iranian Apneic Premature Neonates
801
Pharmacokinetic Interaction of Salbutamol Coadministered with Vasicine Isolated from Adhathoda vasica on Rabbit
802
Pharmacokinetic Interaction Study for Simvastatin and Parsley and Its Plasma Quantification Using LC-MS: A Focus on Drug Metabolic Enzymes
803
Pharmacokinetic interactions between chloroquine, sulfadoxine and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda
804
Pharmacokinetic Interactions between Intravenous Ciprofloxacin and Oral Ferrous Sulfate
805
Pharmacokinetic interactions: The effects of selected herbal extracts on permeation of P-glycoprotein substrate drugs across excised pig intestinal tissue
806
Pharmacokinetic Investigation to Study the In Vivo Bioavailability of Thiolated Chitosan Based Repaglinide Buccal Tablets
807
Pharmacokinetic model for in vivo/in vitro correlation of intravitreal drug delivery
808
Pharmacokinetic model of daily selenium intake from contaminated seafood in Taiwan
809
Pharmacokinetic model of dioxin and furan levels in adipose tissue from Sawmill work involving chlorophenate fungicides
810
Pharmacokinetic of ALA and h-ALA induced porphyrins in the models Mycobacterium phlei and Mycobacterium smegmatis
811
Pharmacokinetic of sulfaclozine in broiler chickens
812
Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. implementation of P3 pyridine N-Oxides to deliver an orally bioavailable series containing P1 N-Benzylamides
813
Pharmacokinetic Parameters and OverResponsiveness of Iranian Population to Propranolol
814
Pharmacokinetic Parameters and Over-Responsiveness of Iranian Population to Propranolol
815
Pharmacokinetic parameters as a potential predictor of response to pharmacotherapy in benign prostatic hyperplasia: a preclinical trial using dynamic contrast-enhanced MRI
816
Pharmacokinetic parameters of valproic acid and carbamazepine from routinely collected data: Influence of patient characteristics
817
Pharmacokinetic profile of a sustained-delivery system for physostigmine in rats
818
Pharmacokinetic Profile of Controlled-Release Carvedilol in Patients with Left Ventricular Dysfunction Associated with Chronic Heart Failure or After Myocardial Infarction
819
Pharmacokinetic Profile of Plasma Levobupivacaine Following Fascia Iliaca Compartment Block for Proximal Femoral Fracture in Older Patient
820
Pharmacokinetic profile of recombination human insulin-like growth factor binding protein-1 in athymic mice
821
Pharmacokinetic Properties of a New Controlled-Release Formulation of Carvedilol
822
Pharmacokinetic studies and human absorbed dose estimation of 68Ga-(4 {[(bis (phosphonomethyl)) carbamoyl] methyl}-7,10-bis(carboxymethy l) -1,4,7,10-tetraazacyclododec-1-yl) acetic acid
823
Pharmacokinetic studies in cancer chemotherapy: Usefulness in clinical practice
824
Pharmacokinetic Studies of Enrofloxacin in Yak after Intramuscular Administration
825
Pharmacokinetic studies of metformin and glibenclamide in normal human volunteers
826
Pharmacokinetic studies of protein drugs: Past, present and future
827
Pharmacokinetic Studies of Rifampicin in Healthy Volunteers and Tuberculosis Patients
828
Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues
829
Pharmacokinetic Studies on Metoprolol - Eudragit Matrix Tablets and Bioequivalence Consideration with Mepressor®
830
Pharmacokinetic Studies on Oximes in Organophosphate Poisoning: A Mini Review
831
Pharmacokinetic Study of a Capsule-based Chronomodulated Drug Delivery System of Salbutamol Sulphate in Rabbits
832
Pharmacokinetic study of acyl-protected hydroxylamine probe, 1-acetoxy-3-carbamoyl-2,2,5,5-tetramethylpyrrolidine, for in vivo measurements of reactive oxygen species
833
Pharmacokinetic study of calenduloside E and its active metabolite oleanolic acid in beagle dog using liquid chromatography–tandem mass spectrometry
834
Pharmacokinetic study of carbamazepine and its carbamazepine 10,11-epoxide metabolite in a group of female epileptic patients under chronic treatment
835
PHARMACOKINETIC STUDY OF CEPHRADINE IN PAKISTANI HEALTHY MALE VOLUNTEERS
836
Pharmacokinetic study of dicloxacillin sodium following intravenous and intramuscular administration to pigs
837
Pharmacokinetic study of dl-tetrahydropalmatine patches by UPLC–MS/MS in rabbits
838
Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract
839
Pharmacokinetic study of free mangiferin in rats by microdialysis coupled with microbore high-performance liquid chromatography and tandem mass spectrometry
840
Pharmacokinetic study of furosemide incorporated PLGA microspheres after oral administration to rat
841
Pharmacokinetic study of HS061, a new human insulin, in non-diabetic rat using ultra performance liquid chromatography–tandem mass spectrometry
842
Pharmacokinetic study of levofloxacin in rat blood and bile by microdialysis and high-performance liquid chromatography
843
Pharmacokinetic study of mangiferin in human plasma after oral administration
844
Pharmacokinetic study of melamine in rhesus monkey after a single oral administration of a tolerable daily intake dose
845
Pharmacokinetic study of multiple active constituents from Kushen–Gancao Decoction after oral administration in rat by HPLC–MS/MS
846
Pharmacokinetic study of mycophenolic acid in Iranian kidney transplant patients.
847
Pharmacokinetic Study of Nifedipine in Healthy Adult Male Human Volunteers
848
Pharmacokinetic study of niosome-loaded insulin in diabetic rats
849
Pharmacokinetic study of orphenadrine using high-performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS)
850
Pharmacokinetic study of three cardiovascular drugs by high-performance liquid chromatography using pre-column derivatization with 9,10-anthraquinone-2-sulfonyl chloride
851
Pharmacokinetic variability of extended interval tobramycin in burn patients
852
PHARMACOKINETIC VARIATIONS OF OFLOXACIN IN NORMAL AND FEBRILE RABBITS
853
Pharmacokinetic, pharmacodynamic and immunogenicity comparability assessment strategies for monoclonal antibodies
854
Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients
855
Pharmacokinetic/pharmacodynamic modeling of antitumor agents encapsulated into liposomes
856
Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology
857
Pharmacokinetic-pharmacodynamic indices of enrofloxacin in Escherichia coli O78/H12 infected chickens
858
Pharmacokinetic-Pharmacodynamic Modeling: Why?
859
Pharmacokinetic–pharmacodynamic models for categorical toxicity data
860
Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep
861
Pharmacokinetics after pulmonary artery perfusion with gemcitabine
862
Pharmacokinetics Alterations of Midazolam Infusion versus Bolus Administration in Mechanically Ventilated Critically Ill Patients
863
Pharmacokinetics and Bioavailability Comparison of two oral Tablet Formulations of Escitalopram 20 mg: A Single-Dose, Open-Label, Two-Period Crossover Study in Healthy Indian Adult Subjects
864
Pharmacokinetics and bioavailability of diisopropanolamine (DIPA) in rats following intravenous or dermal application
865
Pharmacokinetics and bioavailability study of polydatin in rat plasma by using a LC–MS/MS method
866
Pharmacokinetics and Biodistribution of Pegylated Methotrexate after IV Administration to Mice
867
Pharmacokinetics and Biodistribution of Rhopalurus junceus Scorpion Venom in Tumor-Bearing Mice after Intravenous and Oral Administration
868
Pharmacokinetics and Bioequivalence of Methotrexate in Human Plasma Studied by Liquid Chromatography-Mass Spectrometry (LC-MS)
869
Pharmacokinetics and Bioequivalence Study of Two Formulations of Cefixime in Healthy Male Volunteers
870
Pharmacokinetics and brain distribution of unbound levamisole in the anesthetized rats using microdialysis and microbore column liquid chromatography Original Research Article
871
Pharmacokinetics and brain penetration of LF-3-88, (2-[5-[5-(2(S)-azetidinylmethoxyl)-3-pyridyl]-3-isoxazolyl]ethanol), a selective α4β2-nAChR partial agonist and promising antidepressant
872
Pharmacokinetics and Dosage Regimen of Cefepime following Single Dose Intravenous Administration in Calves
873
Pharmacokinetics and Dosage Regimen of Cefpirome in Febrile Cross-Bred Calves
874
PHARMACOKINETICS AND DOSAGE REGIMEN OF CIPROFLOXACIN FOLLOWING SINGLE INTRAMUSCULAR ADMINISTRATION IN TEDDY GOATS
875
Pharmacokinetics and dosimetry of 188Re-pharmaceuticals
876
Pharmacokinetics and Effects of Alkalization after Intravenous Administration of Eltenac in Horses
877
Pharmacokinetics and Effects of Alkalization During Oral and Intravenous Administration of Naproxen in Horses
878
Pharmacokinetics and effects of cetirizine in horses with insect bite hypersensitivity
879
Pharmacokinetics and efficacy of intravenous and extradural tramadol in dogs
880
Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease
881
Pharmacokinetics and ex vivo pharmacodynamics of cefquinome in porcine serum and tissue cage fluids
882
Pharmacokinetics and excretion study of sophoricoside and its metabolite in rats by liquid chromatography tandem mass spectrometry
883
Pharmacokinetics and hemodynamic effects of the phosphodiesterase III inhibitor saterinone in patients with chronic heart failure
884
Pharmacokinetics and hepatotoxicity of diclofenac using an isolated perfused rat liver
885
Pharmacokinetics and in vivo chemosuppressive activity studies on cryptolepine hydrochloride and cryptolepine hydrochloride-loaded gelatine nanoformulation designed for parenteral administration for the treatment of malaria
886
Pharmacokinetics and interaction pharmacodynamics of dexmedetomidine in humans
887
Pharmacokinetics and intramuscular bioavailability of difloxacin in dromedary camels (Camelus dromedarius)
888
Pharmacokinetics and metabolic effects of triamcinolone acetonide and their possible relationships to glucocorticoid-induced laminitis in horses
889
Pharmacokinetics and metabolism of 3,4-dichlorophenyl-propenoyl-sec.-butylamine in rats by high performance liquid chromatography–ion trap mass spectrometry
890
Pharmacokinetics and metabolism of single oral doses of trovafloxacin
891
Pharmacokinetics and metabolism studies on (3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy) pyrazolo[1,5-d][1,2,4]triazine, a functionally selective GABAA α5 inverse agonist for cognitive dysfunction
892
Pharmacokinetics and metabolite identification of a novel VEGFR-2 and Src dual inhibitor 6-chloro-2-methoxy-N-(2-methoxybenzyl) acridin-9-amine in rats by liquid chromatography tandem mass spectrometry
893
Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats
894
Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats
895
Pharmacokinetics and Molecular Docking Studies of Uridine Derivatives as SARSCOV-2 Mpro Inhibitors
896
Pharmacokinetics and Pharmacodynamic Effects of Flunixin after Intravenous, Intramuscular and Oral Administration to Dairy Goats
897
Pharmacokinetics and pharmacodynamic effects of tolazoline following intravenous administration to horses
898
Pharmacokinetics and pharmacodynamics of d-chlorpheniramine following intravenous and oral administration in healthy Thoroughbred horses
899
Pharmacokinetics and Pharmacodynamics of Gliclazide from Immediate and Modified Release Formulation Tablets in Rats
900
Pharmacokinetics and pharmacodynamics of glycoprotein IIb-IIIa inhibitors
901
Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy
902
Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements
903
Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites
904
Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy
905
Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy
906
Pharmacokinetics and pharmacogenomics in gastric cancer chemotherapy
907
Pharmacokinetics and PK-PD modelling of danofloxacin in camel serum and tissue cage fluids
908
Pharmacokinetics and radiation dosimetry estimation of O-(2-[18F]fluoroethyl)-image-tyrosine as oncologic PET tracer
909
Pharmacokinetics and residual behaviour in milk of oxytetracycline in cows following administration of uterine pessaries
910
Pharmacokinetics and residues of a new oral amoxicillin formulation in piglets: A preliminary study
911
Pharmacokinetics and residues of tetracycline in crucian carp muscle using capillary electrophoresis on-line coupled with electrochemiluminescence detection
912
Pharmacokinetics and safety of TP10, soluble complement receptor 1, in infants undergoing cardiopulmonary bypass
913
Pharmacokinetics and tissue and milk disposition of Tilmicosin in sheep after single administrations
914
Pharmacokinetics and tissue distribution of a novel marine fibrinolytic compound in Wistar rat following intravenous administrations
915
Pharmacokinetics and Tissue Distribution of Antimony(v) after Multiple Intramuscular Administrations in the Hamster
916
Pharmacokinetics and tissue distribution of bovine testicular hyaluronidase and vinblastine in mice: an attempt to optimize the mode of adjuvant hyaluronidase administration in cancer chemotherapy
917
Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography–mass spectrometry: Evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier
918
Pharmacokinetics and tissue distribution of the antileukaemic organoarsenicals arsthinol and melarsoprol in mice
919
Pharmacokinetics and Tolerability of Iopromide 240 After Lumbar Myelography
920
Pharmacokinetics in gene delivery
921
Pharmacokinetics in pregnancy
922
Pharmacokinetics in the elderly
923
Pharmacokinetics in the newborn
924
Pharmacokinetics of a long-acting oxytetracycline-polyethylene glycol formulation in horses
925
Pharmacokinetics of a Mono-pyridinium-mono-aldoxime (K-347), a Potential Antidote in Organophosphate Poisoning
926
Pharmacokinetics of a tri-glucoconjugated 5,10,15-(meta)-trihydroxyphenyl-20-phenyl porphyrin photosensitizer for PDT. A single dose study in the rat
927
Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats
928
Pharmacokinetics of alprazolam in elderly patients with multiple diseases
929
Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design
930
Pharmacokinetics of Amoxicillin/Clavulanic Acid Combination after Oral Administration of New Suspension Formulations in Human Volunteers
931
Pharmacokinetics of an ampicillin–sulbactam combination after intravenous and intramuscular administration to neonatal calves
932
Pharmacokinetics of anticancer drugs, plasmid DNA, and their delivery systems in tissue-isolated perfused tumors
933
Pharmacokinetics of betamethasone after maternal or fetal intramuscular administration
934
Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs
935
PHARMACOKINETICS OF CALCIUM FROM CALCIUM SUPPLEMENTS IN HEALTHY VOLUNTEERS
936
Pharmacokinetics of calycopterin and xanthmicrol, two polymethoxylated hydroxyflavones with anti-angiogenic activities from Dracocephalum kotschyi Bioss
937
Pharmacokinetics of Cefepime Following Intravenous and Intramuscular Administration in Sheep
938
Pharmacokinetics of ceftazidime after intravenous and intramuscular administration to domestic cats
939
Pharmacokinetics of ceftazidime in buffalo calves following intravenous and intramuscular administration
940
Pharmacokinetics of ceftiofur sodium in equine pregnancy
941
Pharmacokinetics of ceftriaxone in buffalo calves (Bubalus bubalis) following intravenous and intramuscular administration
942
Pharmacokinetics of Cephalexin in the Horse After Intravenous and Intramuscular Administration of Two Formulations
943
Pharmacokinetics of ciprofloxacin in bath medicated hybrid tilapias using enzyme linked immunosorbent assay (ELISA)
944
PHARMACOKINETICS OF CIPROFLOXACIN IN NORMAL RABBITS AND CHANGES OBSERVED IN INDUCED DEHYDRATED STATE
945
Pharmacokinetics of ciprofloxacin in sheep following intravenous and subcutaneous administration
946
Pharmacokinetics of ciprofloxacin in the rat and its interaction with cyclosporin A: a microdialysis study Original Research Article
947
Pharmacokinetics of Clozapine: An Investigate the Potential Molecular Mechanisms of Action
948
Pharmacokinetics of combined doxorubicin and paclitaxel in mice
949
Pharmacokinetics of conjugated metabolites in rat plasma after oral administration of tectoridin
950
Pharmacokinetics of curcumin-loaded PLGA and PLGA–PEG blend nanoparticles after oral administration in rats
951
Pharmacokinetics of dexamethasone after intravenous and intramuscular administration in broiler chickens
952
Pharmacokinetics of dexamethasone after intravenous and intramuscular administration in pigs
953
Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects
954
Pharmacokinetics of Dextran-70 in patients with cirrhosis and ascites undergoing therapeutic paracentesis
955
Pharmacokinetics of Diclofenac in Sheep Following Intravenous and Intramuscular Administration
956
Pharmacokinetics of Diclofenac in Sheep Following Intravenous and Intramuscular Administration
957
Pharmacokinetics of dl-praeruptorin A after single-dose intravenous administration to rats with liver cirrhosis
958
Pharmacokinetics of Doramectin and Ivermectin After Oral Administration in Horses*
959
Pharmacokinetics of doramectin in lactating dairy sheep and suckling lambs Original Research Article
960
Pharmacokinetics of doxycycline in sheep after intravenous and oral administration
961
Pharmacokinetics of enrofloxacin and flunixin meglumine and interactions between both drugs after intravenous co-administration in healthy and endotoxaemic rabbits
962
Pharmacokinetics of Enrofloxacin and Its Active Metabolite Ciprofloxacin and Its Interaction With Diclofenac After Intravenous Administration in Buffalo Calves
963
Pharmacokinetics of Enrofloxacin and its Metabolite Ciprofloxacin in Goats given Enrofloxacin Alone and in Combination with Probenecid
964
Pharmacokinetics of enrofloxacin and the rate of formation of its metabolite ciprofloxacin following intravenous and intramuscular single dose administration to male buffalo calves
965
Pharmacokinetics of ergosterol in rats using rapid resolution liquid chromatography–atmospheric pressure chemical ionization multi-stage tandem mass spectrometry and rapid resolution liquid chromatography/tandem mass spectrometry
966
Pharmacokinetics of erythromycin after intravenous, intramuscular and oral administration to cats
967
Pharmacokinetics of exogenous gonadotropin and ovarian response in in vitro fertilization
968
Pharmacokinetics of fexofenadine in healthy Taiwanese volunteers
969
Pharmacokinetics of fleroxacin in horses
970
Pharmacokinetics of fluoroquinolones in critical care patients: A bio-analytical HPLC method for the simultaneous quantification of ofloxacin, ciprofloxacin and moxifloxacin in human plasma
971
Pharmacokinetics of gadoversetamide injection, a gadolinium-based contrast agent, in pediatric patients
972
Pharmacokinetics of ganoderic acid D and its main metabolite by liquid chromatography–tandem mass spectrometry
973
Pharmacokinetics of Gefodizime in Patients with Various Degrees of Renal Failure
974
Pharmacokinetics of gentamicin in mares in late pregnancy and early lactation
975
Pharmacokinetics of hydrocodone and hydromorphone after oral hydrocodone in healthy Greyhound dogs
976
Pharmacokinetics of HZ08 in rats by liquid chromatography–tandem mass spectrometry
977
Pharmacokinetics of ingested fluoride: Lack of effect of chemical compound
978
Pharmacokinetics of Intravascularly Administered 65Zinc in Channel Catfish (Ictalurus punctatus)
979
Pharmacokinetics of intravenous and intramuscular parecoxib in healthy Beagles
980
Pharmacokinetics of ionized versus total magnesium in subjects with preterm labor and preeclampsia
981
Pharmacokinetics of kadsurenone and its interaction with cyclosporin A in rats using a combined HPLC and microdialysis system
982
Pharmacokinetics of kakkalide and its main metabolites in rat plasma determined by HPLC-DAD and LC–MSn
983
Pharmacokinetics of ketoprofen enantiomers after intravenous administration of racemate in camels: effect of gender
984
Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia
985
Pharmacokinetics of liposomal aerosolized cyclosporine A for pulmonary immunosuppression
986
Pharmacokinetics of lithium in rat brain regions by spectroscopic imaging
987
Pharmacokinetics of marbofloxacin after intravenous and intramuscular administration to ostriches
988
Pharmacokinetics of marbofloxacin after single intravenous and repeat oral administration to cats
989
Pharmacokinetics of melamine in pigs following intravenous administration
990
Pharmacokinetics of methylphenidate after oral administration of immediate and sustained-release preparations in Beagle dogs
991
Pharmacokinetics of metronidazole in horses after intravenous, rectal and oral administration
992
Pharmacokinetics of metronidazole in rat blood, brain and bile studied by microdialysis coupled to microbore liquid chromatography
993
Pharmacokinetics of mirtazapine and its main metabolites after single intravenous and oral administrations in rats at two dose rates
994
Pharmacokinetics of Mirtazapine and Its Main Metabolites after Single Oral Administration in Fasting/Fed Horses
995
Pharmacokinetics of mirtazapine and its main metabolites in Beagle dogs: A pilot study
996
Pharmacokinetics of oral gabapentin alone or co-administered with meloxicam in ruminant beef calves
997
Pharmacokinetics of oral gabapentin in greyhound dogs
998
Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy, , ,
999
Pharmacokinetics of pefloxacin mesylate in human urine using capillary electrophoresis electrochemiluminescence detection
1000
Pharmacokinetics of Photogem using fluorescence monitoring in Wistar rats
